The store will not work correctly when cookies are disabled.
2-((5-Bromo-2-((2-fluorophenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide
ID: ALA4743962
PubChem CID: 162646739
Max Phase: Preclinical
Molecular Formula: C18H14BrFN4O2
Molecular Weight: 417.24
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CNC(=O)c1ccccc1Oc1nc(Nc2ccccc2F)ncc1Br
Standard InChI: InChI=1S/C18H14BrFN4O2/c1-21-16(25)11-6-2-5-9-15(11)26-17-12(19)10-22-18(24-17)23-14-8-4-3-7-13(14)20/h2-10H,1H3,(H,21,25)(H,22,23,24)
Standard InChI Key: RBSMKPPEJJFWJZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
22.9252 -2.1024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9240 -2.8187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6708 -3.1761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6689 -1.7452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4162 -2.0986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4149 -2.8209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1639 -3.1764 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.1664 -1.7361 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
25.9202 -2.1008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9188 -2.8187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6669 -3.1770 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4169 -2.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4140 -2.0972 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6653 -1.7429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1638 -3.1744 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9096 -2.8164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6704 -3.8900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9239 -4.2467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.4167 -4.2472 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9236 -4.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6551 -3.1771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4003 -2.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3996 -2.1050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6474 -1.7493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9051 -2.1090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6535 -4.0390 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
3 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
16 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 16 1 0
21 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 417.24 | Molecular Weight (Monoisotopic): 416.0284 | AlogP: 4.27 | #Rotatable Bonds: 5 |
Polar Surface Area: 76.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.95 | CX Basic pKa: 0.75 | CX LogP: 4.25 | CX LogD: 4.25 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.65 | Np Likeness Score: -1.63 |
References
1. Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L. (2020) Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer., 208 [PMID:32961380] [10.1016/j.ejmech.2020.112782] |